AGEN Reports $28.6M Revenue, $123.4M Cash, Advances BOT+BAL into Phase 3, Closes $100M Zydus Collaboration
Agenus Inc. · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $3.48
+9.8% in 3d after detection
Post-detection moves
1h
—
1d
+5.5%
3d
+9.8%
7d
-3.4%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS